95 related articles for article (PubMed ID: 382502)
1. Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.
Suthanthiran M; Fotino M; Gibofsky A; Cheigh JS; Stenzel KH; Rubin AL; Novogrodsky A
Transplant Proc; 1979 Jun; 11(2):1263-4. PubMed ID: 382502
[No Abstract] [Full Text] [Related]
2. D lucus antigen defined lymphoblastoid cell panel allows detection of hitherto undetected adverse presensitization.
Suthanthiran M; Fotino M; Cheigh JS; Novogrodsky A; Rubin AL; Stenzel KH
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():199-202. PubMed ID: 386312
[No Abstract] [Full Text] [Related]
3. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
[TBL] [Abstract][Full Text] [Related]
4. Anti-donor antibody responses. Recipient presensitization and renal allograft survival.
Keown P; Stiller CR; Sinclair NR; Fung M; McGirr D; Moseley P; Howson W; Ulan RA
Transplant Proc; 1978 Jun; 10(2):459-62. PubMed ID: 354135
[No Abstract] [Full Text] [Related]
5. The detection and measurement of pretransplant sensitization.
Carpenter CB; Morris PJ
Transplant Proc; 1978 Jun; 10(2):509-13. PubMed ID: 150085
[No Abstract] [Full Text] [Related]
6. Cytotoxic antibodies to B lymphocytes in kidney transplant patients.
Luciani G; Castagneto M; Monari C; Renna E
Transplant Proc; 1979 Jun; 11(2):1265-6. PubMed ID: 382503
[No Abstract] [Full Text] [Related]
7. Prediction of kidney graft survival by sensitive crossmatch tests and the use of effector cell function (ECA) as a predictor of rejection.
McConnachie PR; Finch WT; Birtch AG
Transplant Proc; 1979 Jun; 11(2):1256-7. PubMed ID: 382501
[No Abstract] [Full Text] [Related]
8. Enhancing antibody in human renal transplantation.
Iwaki Y; Terasaki PI; Heintz R; Cardman L; Hermes M
Transplant Proc; 1979 Dec; 11(4):1899-902. PubMed ID: 394435
[No Abstract] [Full Text] [Related]
9. Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens.
Suthanthiran M; Gailiunas P; Person A; Fagan G; Strom TB; Carpenter CB; Garovoy MR
Transplant Proc; 1978 Jun; 10(2):471-3. PubMed ID: 354138
[No Abstract] [Full Text] [Related]
10. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
[No Abstract] [Full Text] [Related]
11. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
Hirschberg H; Moen T; Thorsby E
Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
[No Abstract] [Full Text] [Related]
12. Alloantibodies and outcomes of deceased donor kidney allografts.
Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
[TBL] [Abstract][Full Text] [Related]
13. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets.
Nathan P; Plessinger RT; First MR
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():62-7. PubMed ID: 386322
[TBL] [Abstract][Full Text] [Related]
14. Graft survival with high levels of cytotoxic antibodies.
Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
[TBL] [Abstract][Full Text] [Related]
15. A negative T cell crossmatch is adequate to permit successful renal transplantation.
Lowry RP; Myrberg S; Goguen JE; Carpenter CB; Cho S; Garovoy MR
Proc Clin Dial Transplant Forum; 1979; 9():201-4. PubMed ID: 399507
[No Abstract] [Full Text] [Related]
16. B lymphocyte crossmatching: lack of effect on transplant outcome based on incubation temperature.
Ettenger RB; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Fine RN
Proc Clin Dial Transplant Forum; 1979; 9():197-200. PubMed ID: 399506
[No Abstract] [Full Text] [Related]
17. Prognostic significance of B and T cell antibodies in kidney transplantation.
Lenhard V; Rettwitz W; Dreikorn K; Röhl L
Proc Eur Dial Transplant Assoc; 1980; 17():478-82. PubMed ID: 7017693
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
19. B-cell antibodies and clinical kidney transplantation.
Myburgh JA; Smit JA
Transplant Proc; 1978 Sep; 10(3):599-601. PubMed ID: 362641
[No Abstract] [Full Text] [Related]
20. Immunologic monitoring of the renal transplant recipient.
Suthanthiran M; Garovoy MR
Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
